A recent study found that symptomatic Lrrk2 mutation carriers showed increased levels of pro-inflammatory marker fatty-acid protein, similar to sporadic PD (sPD), but, unlike sPD, they did not show increased levels of the pro-inflammatory markers of interleukin-12-p40. This evidence concerns the gene LRRK2 and Parkinson disease.